Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study - Quiz - MDSpire

Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study

  • By

  • Haoran Xu

  • Fangce Wang

  • Chenbo Sun

  • Bing Xiu

  • Yi Ding

  • Bin Xue

  • Aibin Liang

  • Wenjun Zhang

  • July 7, 2026

  • 0 min

Share

Original Source(s)

Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study

  • by Haoran Xu, Fangce Wang, Chenbo Sun, Bing Xiu, Yi Ding, Bin Xue, Aibin Liang, Wenjun Zhang

  • July 7, 2026

Related Content

Integrative analysis of GEO data on the microbial community in colorectal cancer tissues and its impact on the tumor immune microenvironment

Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review

Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort